ZIVO — Zivo Bioscience Balance Sheet
0.000.00%
- $47.75m
- $48.22m
- $0.16m
Annual balance sheet for Zivo Bioscience, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.138 | 8.9 | 1.8 | 0.274 | 1.54 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | — | — | 0.004 | 0.002 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.168 | 8.96 | 1.9 | 0.425 | 1.64 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.049 | 0.027 | 0.189 | 0.098 | 0 |
| Long Term Notes Receivable | |||||
| Total Assets | 0.22 | 8.99 | 2.12 | 0.556 | 1.64 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11.4 | 2.95 | 2.03 | 2.76 | 2.04 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 11.5 | 2.95 | 2.13 | 2.76 | 2.16 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -11.3 | 6.04 | -0.011 | -2.21 | -0.515 |
| Total Liabilities & Shareholders' Equity | 0.22 | 8.99 | 2.12 | 0.556 | 1.64 |
| Total Common Shares Outstanding |